Bank Nationalnobu Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Bank Nationalnobu Tbk. trades at Rp448 (market cap 3.3T, 818.5K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp254 (market cap 172.82B, 592.2K 24h volume). The key difference: Bank Nationalnobu Tbk. is far larger — about 19.1× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Bank Nationalnobu Tbk. is more actively traded (818.5K versus 592.2K). Which is the better fit depends on your goals.
| NOBU | OBAT | |
|---|---|---|
Market Cap | 3.3T | 172.82B |
Volume | 818.5K | 592.2K |
Lot | 8.19K | 5.92K |
Turnover | 366.37M | 147.05M |
Average Price | 447.61 | 248.31 |
Value | 366.37M | 147.05M |
Indicative Equilibrium Price | 448 | 254 |
Indicative Equilibrium Volume | 78 | 10 |
Trailing returns across standard periods
Latest headlines on both assets
PT Bank Nationalnobu Tbk (formerly PT Bank Alfindo) was established in Jakarta on February 13, 1990 based on the Notarial Deed No. 86 from Drs. Entjoen Mansoer Wiriatmadja, S.H., a notary in Jakarta.
Read more on NOBU →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →